Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients

Providence Health & Services

Status: Terminated

Conditions: Heart Failure

Treatments: Other: Home medication if needed; Other: Discharge medication counseling from a pharmacist; Other: Follow-up visit at Medication Therapy Management clinic

Study type: Interventional

Funder types: Other

Identifiers

NCT01822171

PSPH-002-Pharm

Details and patient eligibility

About

Readmission to a hospital shortly after discharge is a common and costly problem. In the United States patients with a diagnosis of heart failure currently experience an elevated 30 day readmission rate of approximately 20%. By providing patients with medication related counseling at discharge by a pharmacist, home medications at discharge, and seeing the patient again in a pharmacist-run Medication Therapy Management (MTM) clinic 7 days after discharge, the study anticipates achieving its primary goal of showing a reduction in the readmission rate. Secondary goals are: 1) to determine patients understanding of the medication they are taking, 2) to evaluate satisfaction with the comprehensive discharge counseling service, and 3) determine the number of interventions made and benefit of the MTM clinic.

Full description

The active arm of this study (medication related hospital discharge counseling by a pharmacist, home medications, and 7 day follow-up visit at a pharmacist run MTM clinic) is available to all subjects. To study the primary goal of reducing the 30 day readmission rate the data obtained from the active arm subjects will be compared to a match group of hospitalized patients that were previously discharged with a diagnosis of heart failure. The data for all secondary study goals will be obtained directly from the active arm subjects.

Enrollment: 1 patient

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Heart Failure with high risk for readmission.
• Enroll in study prior to hospital discharge.

Exclusion criteria

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1 participants in 1 patient group

Discharge counseling and MTM follow-up

Experimental group

Description:

At the time of hospital discharge the subject will receive: * Discharge medication counseling from a pharmacist * Home medication if needed * Approximately 7 days after hospital discharge the subject have a Follow-up visit at Medication Therapy Management clinic.

Treatment:

Other: Discharge medication counseling from a pharmacist

Other: Home medication if needed

Other: Follow-up visit at Medication Therapy Management clinic